Global Onychomycosis Market Size By Product (Antifungal Medications, Non-Pharmacological Products), By Treatment (Pharmacological, Non-Pharmacological), By Geographic Scope And Forecast

Onychomycosis Market Size And Forecast

Onychomycosis Market size was valued at USD 4.2 Billion in 2022 and is projected to reach USD 6.45 Billion by 2030, growing at a CAGR of 5.5% from 2023 to 2030.

The increasing number of diabetes patients, an aging population, and rising health care expenditures per capita are all factors that are supporting the Onychomycosis Market. The Onychomycosis Market has seen growth as a result of rising health consciousness and higher levels of discretionary money. The Global Onychomycosis Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Onychomycosis Market Definition

So, you might know it as onychomycosis, but it's really just a fungal infection that messes with your nails – making them change color, get thicker, and even pull away from the nail bed. Yep, that's onychomycosis, or sometimes called tinea unguium. There are different ways it can show up, like distal subungual onychomycosis, white superficial onychomycosis (WSO), proximal subungual onychomycosis, or even candidal onychomycosis. What causes it? Usually, it's fungi like dermatophytes, Candida (that's a yeast), or other molds. In places like the US and Europe, dermatophytes are often the culprit. But if you're hanging out in a hot, humid spot, you're more likely to get it from candida or those non-dermatophyte molds.

Think you might have a nail fungus, also known as onychomycosis? It's an infection caused by fungi that can mess with your fingernails or toenails. And it's not just a cosmetic issue! It can cause major problems like nail deformity, discomfort, and even pain, and in some cases, lead to serious complications. How do you know if you have it? Look for brittle, ragged, or crumbly nails and maybe even a not-so-pleasant odor. Your nails might also change shape. What causes onychomycosis? Things like a weakened immune system, diabetes, circulation problems, excessive sweating, decreased blood flow, psoriasis, or just being around fungi a lot can all contribute. Here's a rundown of symptoms. By the way, the market for onychomycosis treatments is expected to grow due to the increasing population and more cases of nail fungus. Good news is there are treatments available, including medicines, photodynamic therapy, and even laser therapy.

Hey, so the Onychomycosis Market is probably going to get bigger! Why? Because companies are working hard to create new drugs and ways to treat nail fungus. It's a bigger deal than people think, because onychomycosis can really mess with your life - emotionally, socially, and even at work. It can even lead to people feeling ashamed and isolated. Even though money and other health problems often take priority, better medicine in the last 20 years means more people are actually getting treatment. Plus, more folks are getting diagnosed, which is raising awareness and making people want effective treatments!

Global Onychomycosis Market Overview

The Onychomycosis Market is expected to grow, thanks to a few thingsmore people getting diabetes, an aging population, and rising healthcare costs for everyone. In the US, increasing health awareness and more disposable income are really helping the Onychomycosis Market out! However, there are some bumps in the road – like people not knowing enough about the condition and worries about medication side effects – that could slow things down. While COVID-19 did shake things up for the healthcare system, it's thought to only have a temporary impact on the Market.

Fewer check-ups seem to mean fewer people are actually using treatments, which is hurting the market. Plus, because people are trying to avoid catching something nasty at the doctor's office, they're skipping visits, and that's also causing sales to drop. To be honest, toenail fungus (onychomycosis) isn't usually high on the priority list compared to other serious health issues. Because it's often seen as "not that bad," sales have really taken a hit during COVID-19. But there's hope! Oral treatments are proving to be a real game-changer for the Onychomycosis Market. Lots of people prefer popping a pill like Ciclodan, ciclopirox, Jublia, efinaconazole, or Penlac, and that's a big reason why the market is growing.

As we get older, our nails become more prone to fungal infections (onychomycosis) for a bunch of reasons. Think about ityears of being exposed to nasty fungi, little nail injuries over time, diabetes, or just a weaker immune system. Plus, if you're not as active or have trouble cutting your toenails and taking care of your feet, it's easier for fungus to take hold. To compete, domestic companies are really stepping up their game. They're investing in research and development, merging with or buying other companies (mergers and acquisitions), and launching brand new products. People are really liking the oral medications because they work well and are super convenient. Because of all this, the Onychomycosis Market could really take off as more people use these medicines.

The Onychomycosis Market is poised to benefit from the multiple prospects for expansion brought about by the numerous initiatives that are done by the government bodies in numerous countries to modernize the healthcare infrastructure. In addition, an increase in awareness efforts regarding onychomycosis from both the government and non-governmental groups has been shown to be a development driver for the Onychomycosis Market. The burgeoning industry of medical tourism across a wide variety of places is contributing to the significantly increased growth rate.

Global Onychomycosis Market Segmentation Analysis

The Global Onychomycosis Market is Segmented on the basis of Product, Treatment, And Geography.

Onychomycosis Market, By Product

• Antifungal Medications
• Non-Pharmacological Products
• Nail Care Products
• Others

Based on Product, the market is segmented into Antifungal Medications, Non-Pharmacological Products, Nail Care Products, and Others. The Nail Care Products segment will dominate the market. An increase in the prevalence of topical nail lacquers can be seen as a trend in the market when compared with antifungal drugs. The tablet segment may grow because of the factor that the government is trying to switch to generic drugs.

Onychomycosis Market, By Treatment

• Pharmacological
• Non-Pharmacological
• Others

Based on Treatment, the market is segmented into Pharmacological, Non-Pharmacological, and Others. For the treatment of fungal nail infections, both topical and oral medicines are available. The major goal of therapy, as evidenced by microscopy and culture, is to completely eliminate the organism from the body. The oral medications griseofulvin, terbinafine, itraconazole, and ketoconazole are the most usually used for the treatment of onychomycosis. The downsides of oral antifungal medicines, such as terbinafine, are that they need a longer treatment time and have greater side effects than topical antifungal drugs.

Onychomycosis Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Geographically speaking, the global market for onychomycosis (that's nail fungus, by the way!) breaks down into North America, Europe, Asia Pacific, and, well, everywhere else. North America is expected to be a major player, mostly because of expensive medications, a growing senior population, and unfortunately, more and more people dealing with both onychomycosis and diabetes. Why are older folks more prone to nail fungus? Lots of reasons! Things like nail injuries that add up over time, poor blood flow, diabetes itself, weaker immune systems, longer exposure to those pesky fungi, less activity, and even just having a harder time taking care of their feet. The older you get, the higher the risk. Local companies are really stepping up their game to compete, focusing on things like research and development, merging with or buying other companies, and launching innovative new products.

Key Players

The “Global Onychomycosis Market” study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Bausch Health Companies Inc. (Valeant Pharmaceuticals Inc.), Galderma SA, Novartis AG, Pfizer Inc., Moberg Pharma AB, Johnson & Johnson, Bayer AG, Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Medimetriks Pharmaceuticals Inc.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

• In April 2021, Alembic Pharmaceuticals Limited (Alembic) made the announcement that it has gained tentative approval from the US Food and Drug Administration for its joint venture Aleor Dermaceuticals Limited (Aleor).
• Lupin Limited was granted permission by the Food and Drug Administration of the United States in February 2021 for its Tavaborole Topical Solution, which was designed to treat onychomycosis.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We'll dive into the market using both qualitative and quantitative analysis, breaking it down into segments based on things like the economy and even factors beyond the numbers. You'll get market value data in USD Billion for every segment and sub-segment we identify. We'll also point out which region and segment are likely to grow the fastest and which ones will be the biggest. Our analysis looks at each geographic area, examining how much of the product/service is being used and what's influencing the market there. Speaking of competition, we'll show you the market ranking of the major players, and highlight their new services/products, partnerships, expansions, and acquisitions from the last five years in detailed company profiles. These profiles include company overviews, insights, product benchmarking, and a SWOT analysis for each major player. You'll get a feel for where the market is now and where it's headed, considering recent developments, growth opportunities, drivers, and challenges in both new and established regions. We'll also provide an in-depth look at the market from different angles using Porter's Five Forces analysis and give you valuable insights through the Value Chain. Finally, we’ll cover the market dynamics scenario and identify growth opportunities for the future, plus you get 6-month post-sales analyst support; consider us your market guide! Learn more.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.